Misagh Naderi

Biography
Misagh serves as a liaison between domain experts in pathology, artificial intelligence, and biopharma at Reveal Biosciences, a frontier in digital pathology. Misaghs scientific expertise spans across computational biology, cancer research, and chemical engineering with publications in protein modeling, in-silico drug design, and oncolytic virology. His work at Reveal Biosciences aims to help biotech and pharma companies in their preclinical and clinical research to modernize drug development and patient treatments. Before joining Reveal Biosciences, Misagh served as a scientific advisor at two prominent international law firms, focusing on intellectual property and innovations at the intersection of biology, engineering, and artificial intelligence. He has a passion for the business of science, science communication, and translating innovations in AI and digital health into solutions that tangibly improve human health and well-being.

---

Talk
Precision Pathology: AI-Driven Spatial Analysis of Tumor Microenvironment
Multiplex immunofluorescence (MIF) in precision histopathology is transforming spatial biology and cancer research. Reveal Biosciences offers AI-driven digital assays, paired with cutting-edge multiplex immunofluorescent lab services to explore spatial interactions in the tumor microenvironment. The result is an interactive visualization environment to explore highly reproducible quantifiable readouts and actionable spatial metrics.

Spatial Showcase:
Reveal Biosciences
Reveal Biosciences pioneers AI-powered pathology and spatial biology, delivering cutting-edge tissue insights to empower biopharmaceutical research and global healthcare.